GlassScriptPhysician profile
Anthony Roda-Renzelli
NPI 1992803506
$3,564.30
in general payments reported to CMS, 2019-2025
27 companies · $1,041 in 2025
The $1,041 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $374 · 2021: $324 · 2022: $90.72 · 2023: $186 · 2024: $1,157 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $561.28 | 2019-2020 | |
| Medtronic, INC. | $406.24 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $377.25 | 2022-2025 | Rotapro, Amplatz Super Stiff, Avvigo Guidance System |
| Recor Medical INC | $207.74 | 2024 | Paradise Renal Denervation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.75 | 2023-2025 | Lifevest |
| Teleflex LLC | $173.88 | 2025 | Orsiro Mission |
| Novartis Pharmaceuticals Corporation | $156.13 | 2023-2025 | |
| Edwards Lifesciences Corporation | $154.14 | 2019 | |
| Terumo Medical Corporation | $142.55 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $140.12 | 2023-2025 | Eliquis, Camzyos |
| Stryker Corporation | $126.49 | 2025 | Artix Mt, Flowtriever |
| Abbott Laboratories | $120.29 | 2019-2024 | Amplatzer Amulet |
| Asahi Intecc USA, INC. | $119.80 | 2021 | |
| Abiomed | $114.08 | 2024-2025 | Impella |
| Journey Medical Corporation | $111.66 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $105.49 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $97.40 | 2024-2025 | (5044) Mcot, Diagnostic Ecg Service, (Bq9) Coronary Ivus |
| Astrazeneca Pharmaceuticals LP | $57.21 | 2023-2024 | Wainua, Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $56.28 | 2023-2024 | Xarelto |
| Livanova USA, INC. | $27.32 | 2019 | |
| Esperion Therapeutics, INC. | $23.34 | 2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $19.78 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $18.39 | 2025 | |
| Pfizer INC. | $15.16 | 2025 | |
| Lemaitre Vascular, INC. | $14.77 | 2025 | Hydro Lemaitre Valvulotome |
| Merck Sharp & Dohme LLC | $14.67 | 2023 | Verquvo |
| Heartflow, INC. | $14.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Roda-Renzelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.